Concepedia

Author

D. J. Nichols

Pfizer (United Kingdom)

Also Known As

D J Nichols, D. J. D. NICHOLS, D. J. NICHOLS, D. J. Nichols, D.J. Nichols, Don J Nichols, Don Nichols

25

Publications

962

Citations

15

H-Index

37

Concepts

All Affiliations

Pfizer (United Kingdom)Pfizer (Belgium)Erasmus Hospital
DJ

About

D. J. Nichols is an author at Pfizer (United Kingdom) specializing in medicine, endocrinology, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

225

2

Public Health

3

3

72

3

Biology

2

2

33

4

Natural Sciences

1

1

13

5

Biochemistry

1

1

13

D. J. Nichols

×

17

Publications

941

Citations

15

H-Index

YearCitations

Effect of food on the pharmacokinetics of multiple‐dose oral voriconazole

Lynn Purkins, Nolan Wood, Diane Kleinermans,

British Journal of Clinical Pharmacology

2003

160

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

Lynn Purkins, Nolan Wood, Katie Greenhalgh,

British Journal of Clinical Pharmacology

2003

115

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

Nolan Wood, Keith Tan, Lynn Purkins,

British Journal of Clinical Pharmacology

2003

105

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

Lynn Purkins, Nolan Wood, Diane Kleinermans,

British Journal of Clinical Pharmacology

2003

81

Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract

Howard N.E. Stevens, Clive Wilson, Peter G. Welling,

International Journal of Pharmaceutics

2002

68

Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon

Nicola Clear, Ashley Milton, Michael Humphrey,

European Journal of Pharmaceutical Sciences

2001

52

Cortisol dynamics during seawater adaptation of Atlantic salmon Salmo salar

D. J. Nichols, Melvin Weisbart

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

1985

50

Voriconazole does not affect the steady‐state pharmacokinetics of digoxin

Lynn Purkins, Nolan Wood, Diane Kleinermans,

British Journal of Clinical Pharmacology

2003

44

Pharmacokinetics and metabolism of darifenacin in the mouse, rat, dog and man

Kevin Beaumont, N. J. CUSSANS, D. J. Nichols,

Xenobiotica

1998

43

Histamine H<sub>2</sub>‐receptor antagonists have no clinically significant effect on the steady‐state pharmacokinetics of voriconazole

Lynn Purkins, Nolan Wood, Diane Kleinermans,

British Journal of Clinical Pharmacology

2003

42

Page 1